Related Experiment Video
Updated: Feb 11, 2026

Eye Tracking During Visually Situated Language Comprehension: Flexibility and Limitations in Uncovering Visual Context Effects
Published on: November 30, 2018
Analysis of the world epidemiological situation among vancomycin-resistant Enterococcus faecium infections and the
Katarzyna Talaga-Ćwiertnia1, Małgorzata Bulanda2
1Department of Mycology, Chair of Microbiology, Faculty of Medicine Jagiellonian University Medical College, Kraków
Abstract:
Vancomycin-resistant Enterococcus faecium (VREfm) strains have become an important hospital pathogen due to their rapid spread, high mortality rate associated with infections and limited therapeutic options. Vancomycin resistance is predominantly mediated by VanA or VanB phenotypes, which differ as regards maintaining sensitivity to teicoplanin in the VanB phenotype. The majority of VREfm cases in the United States, Europe, Korea, South America and Africa are currently caused by the VanA phenotype. However, the epidemics in Australia and Singapore are chiefly brought about by the VanB phenotype. The rate of VREfm isolate spread varies greatly. The greatest percentage of VREfm is now recorded in the USA, Ireland and Australia. Supervision of VRE is implemented to varying degrees. Therefore, the epidemiological situation in some countries is difficult to assess due to limited data or lack thereof.
Insights
Vancomycin-resistant Enterococcus faecium (VREfm) is a significant hospital pathogen. Resistance varies by VanA and VanB phenotypes, impacting treatment options and global spread patterns.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Vancomycin-resistant Enterococcus faecium (VREfm) is a critical hospital-acquired pathogen.
- VREfm infections are associated with high mortality and limited treatment choices.
- Vancomycin resistance is primarily mediated by VanA or VanB phenotypes.
Purpose of the Study:
- To analyze the global epidemiology of Vancomycin-resistant Enterococcus faecium (VREfm).
- To differentiate VREfm prevalence based on VanA and VanB resistance phenotypes.
- To assess the varying rates of VREfm spread and reporting worldwide.
Main Methods:
- Review of global epidemiological data on VREfm isolates.
- Phenotypic characterization of vancomycin resistance (VanA vs. VanB).
- Analysis of VREfm prevalence and spread rates across different geographic regions.
Main Results:
- The VanA phenotype is dominant in most regions (USA, Europe, Asia, South America, Africa).
- The VanB phenotype is predominant in Australia and Singaporean epidemics.
- VREfm prevalence is highest in the USA, Ireland, and Australia, with significant regional variations in spread rates.
Conclusions:
- Understanding the geographic distribution of VanA and VanB phenotypes is crucial for targeted interventions.
- Inconsistent VRE surveillance limits accurate assessment of the global epidemiological situation.
- Effective VRE control strategies require tailored approaches based on local resistance patterns and spread dynamics.
More Related Videos
Related Concept Videos
Mesh Analysis with Current Sources
Current Source in One Mesh: The analysis process is straightforward when a current source is found in only one mesh within the circuit. Mesh currents are assigned as usual, with the mesh containing the current source excluded from the analysis. Kirchhoff's voltage law...
Introduction to Epidemiology
Causality in Epidemiology
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Confounding in Epidemiological Studies
Bias in Epidemiological Studies

